Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dentsply Sirona (XRAY) Change in Account Payables (2016 - 2025)

Dentsply Sirona (XRAY) has disclosed Change in Account Payables for 17 consecutive years, with $20.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Account Payables rose 183.33% year-over-year to $20.0 million, compared with a TTM value of $11.0 million through Dec 2025, up 136.67%, and an annual FY2025 reading of $11.0 million, up 136.67% over the prior year.
  • Change in Account Payables was $20.0 million for Q4 2025 at Dentsply Sirona, up from $1.0 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $30.0 million in Q2 2022 and bottomed at -$28.0 million in Q1 2024.
  • Average Change in Account Payables over 5 years is -$1.2 million, with a median of -$2.5 million recorded in 2021.
  • The sharpest move saw Change in Account Payables soared 1800.0% in 2024, then plummeted 241.18% in 2025.
  • Year by year, Change in Account Payables stood at -$4.0 million in 2021, then plummeted by 150.0% to -$10.0 million in 2022, then surged by 340.0% to $24.0 million in 2023, then tumbled by 200.0% to -$24.0 million in 2024, then soared by 183.33% to $20.0 million in 2025.
  • Business Quant data shows Change in Account Payables for XRAY at $20.0 million in Q4 2025, $1.0 million in Q3 2025, and -$24.0 million in Q2 2025.